drugset / Trial / NCT01266434

The Additive Anti-inflammatory Effect of Simvastatin in Combination With Inhaled Corticosteroids on p38 MAPK in Asthma

NCT01266434

Phase 3 Completed 44 enrolled Mahidol University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To test whether simvastatin has an additional anti-inflammatory effects on p38 MAPK, a signaling molecule for inflammation in inhaled steroid-treated asthmatics.

Timeline

Start
2011-01
Primary completion
2016-02
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule 10 mg

Indications